Bimekizumab Clinical Trials
7 recruitingDrug
Phase 33Phase 41Phase 21Phase 11
Showing 1–7 of 7 trials
Recruiting
Phase 1
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Hidradenitis SuppurativaPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL20 enrolled12 locationsNCT06888193
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Palmoplantar Pustulosis
UCB Biopharma SRL300 enrolled41 locationsNCT07219420
Recruiting
Phase 3
A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
UCB Biopharma SRL40 enrolled18 locationsNCT06921850
Recruiting
Phase 3
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
UCB Biopharma SRL40 enrolled23 locationsNCT06668181
Recruiting
Phase 2
Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
Psoriasis
Centre Hospitalier Universitaire de Nice40 enrolled7 locationsNCT06742333
Recruiting
Phase 4
Bimekizumab in Plaque Psoriasis
Plaque Psoriasis
Icahn School of Medicine at Mount Sinai60 enrolled2 locationsNCT06336343
Recruiting
Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
DepressionPsoriatic ArthritisPsoriatic Plaque
NHS Greater Glasgow and Clyde50 enrolled1 locationNCT06786936